Lidocaine Hydrochloride Topical Solution — Class I drug recall D-0800-2021
Ongoing recall by Teligent Pharma, Inc., reported 2021-09-22, distributed nationwide. Superpotent Drug
| Recall number | D-0800-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teligent Pharma, Inc., Buena, NJ, United States |
| Recall initiated | 2021-08-03 |
| Classified | 2021-09-15 |
| Reported by FDA | 2021-09-22 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Quantity | 32,544 glass |
| Reason classes | potency |
| NDC | 52565-0009-50 |
| Lot numbers | 14218 |
| Expiration dates | 2022-08 |
Product
Lidocaine Hydrochloride Topical Solution, USP, 4% , 50 mL glass bottles, Rx Only, Teligent Pharma Inc. Buena, New Jersey 08310, NDC 52565-009-50.
Reason for recall
Superpotent Drug
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0800-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.